I-Ally Partners with Breakthrough Alzheimer’s Disease Diagnostic Tool

SYNAPS Dx, a privately held company focused on the research, development and commercialization of diagnostics for neurological disorders and conditions, has released DISCERN™, the first accurate, minimally invasive test for the definitive diagnosis of Alzheimer’s disease (AD) versus other forms of dementia.